Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD – Get Free Report) saw some unusual options trading activity on Wednesday. Investors purchased 2,853 call options on the stock. This is an increase of 160% compared to the typical daily volume of 1,096 call options.
Institutional Trading of Direxion Daily S&P Biotech Bear 3x Shares
Several institutional investors have recently made changes to their positions in LABD. Jump Financial LLC acquired a new position in Direxion Daily S&P Biotech Bear 3x Shares in the 4th quarter worth about $363,000. Headlands Technologies LLC acquired a new stake in Direxion Daily S&P Biotech Bear 3x Shares in the fourth quarter valued at approximately $420,000. Two Sigma Securities LLC bought a new stake in Direxion Daily S&P Biotech Bear 3x Shares in the fourth quarter worth approximately $444,000. Finally, Virtu Financial LLC increased its stake in shares of Direxion Daily S&P Biotech Bear 3x Shares by 133.6% during the 4th quarter. Virtu Financial LLC now owns 1,300,443 shares of the company’s stock worth $9,428,000 after purchasing an additional 743,793 shares during the last quarter.
Direxion Daily S&P Biotech Bear 3x Shares Stock Performance
LABD opened at $9.49 on Thursday. The stock has a fifty day moving average of $7.44 and a 200-day moving average of $6.67. Direxion Daily S&P Biotech Bear 3x Shares has a 12-month low of $4.78 and a 12-month high of $11.41.
Direxion Daily S&P Biotech Bear 3x Shares Cuts Dividend
Direxion Daily S&P Biotech Bear 3x Shares Company Profile
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bear 3x Shares
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 5 Reasons the S&P 500 Could Rebound Strongly in 2025
- Insider Trades May Not Tell You What You Think
- Best Gold Stocks in 2025… So Far
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 5 Reasons Why Halliburton is a Good Buy in 2025
Receive News & Ratings for Direxion Daily S&P Biotech Bear 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bear 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.